One way to determine rate of percutaneous absorption is dose-response comparisons following this mode of administration and intravenous infusion. This method has been discussed in detail by Fredriksson (1) and Griesemer et at.
this mode of administration and intravenous infusion. This method has been discussed in detail by Fredriksson (1) and Griesemer et at.
(2) in connection with measurements of the rate of absorption of an organophosphorus eholinesterase inhibitor, sarin. The last-mentioned authors chose inhibition of blood eholinesterase activity in the rabbit as a basis for the doseresponse comparison. It was decided to use the same parameter in connection with the two routes of administration in order to determine the rate of percutaneous absorption of paraoxon, a compound that belongs to the same pharmacologic group as sarin, but to modify the technic in several respects in order to improve the accuracy. Thus, the eat was selected as experimental animal, since this species has higher plasma eholinesterase activity than the rabbit. A higher activity makes the individual determinations of enzyme activity more accurate. Furthermore, it was decided to adjust the rate of infusion so that it corresponded as closely as possible to the rate of percutaneous absorption, since the distribution of organophosphorus compounds, their detoxification and, thus, the proportion available for enzyme inhibition is dependent on the rate of systemic administration (see review by Holmstedt, 3). Since there obviously must be a latency period before the topically applied material will reach the blood stream and produce inhibition of the enzyme activity, an adjustment of the rate of infusion so that the degree of enzyme inhibition after a given interval is the same as the degree of inhibition after the same interval following percutaneous application by necessity must result in too low values concerning the rate of percutaneous absorption. This potential error may be increased also if (4) , it was found to contain only traces of pnitrophenol.
Twelve cats, weighing between 2.6 and 3.0 kg, were used. They were anesthetized with sodium pentobarbital, 25 mg per kg body weight, administered intraperitoneally. In all the animals, the trachea and one carotid artery were cannulated. Blood samples were taken from the carotid artery every 30 minutes for 4 to 5 hours.
In the animals used for intravenous infusion, the left femoral vein was cannulated. In this case, the paraoxon was dissolved in propylene glycol, and the rate of infusion was adjusted to 1.0 ml per hour with the aid of an infusion pump.
The concentration of paraoxon was varied between 128 and 32 pg per ml. In the animals used for percutaneous absorption, 50 p1 of undiluted paraoxon was evenly distributed over 4.1 em2 on a clipped area on the lateral aspect of the left thigh, as described earlier (5). Plasma was separated by centrifugation, and the enzyme activity was determined with the Warburg technic, using aeetyleholine as substrate. The activity values, expressed as percentage of the 0-time value, were plotted in a semi-logarithmic system as ordinates against time When plotted, the values whree. the inhibition approached asymptotic regions were omitted, and the 0-time value was omitted also because the latency period must be taken into account. In order to compare the slopes of the curves, the velocity constant of the inhibition of the enzyme activity was derived from the conventional formula.
A1 = A,

RESULTS AND DISCUSSION
Cholinergic signs, such as salivation, miosis and fasciculations in different muscles, appeared occasionally in both groups of animals. The only local symptom following percutaneous absorption was fasciculations in the muscles underlying the area of application; this sign usually appeared one hour from application.
Both forms of administration resulted in inhibition curves, which followed straight lines when plotted in a semi-logarithmic system, as it is a well known fact that the inhibition of cholinesterases by paraoxon is a first order reaction, the form of the curves means that the rate of percutaneous absorption is constant in a given skin when conditions such as temperature remain constant. This result confirms findings obtained in vitro (6) and in vivo (1) Table 1 . The rates of percutaneous absorption of active paraoxon into the blood stream can be calculated easily from these velocity constants. The absorption rates were approximately 0.13 to 0.26 pg mm em2, or 0.47 to 0.95 mpM mm .em2. It must be remembered that these values represent only the rate of absorption of active inhibitor into the blood stream.
The disappearance rate from the topical deposit might be considerably higher than the absorption rate, since part of the material may be detoxified during diffusion through the skin. In an earlier investigation (4), it was shown that eat skin contains an enzyme that is capable of hydrolyzing paraoxon. Those results indicated that cat skin was capable of splitting approximately 30 pg paraoxon per hour and gram of tissue (1 g of cat skin equals 12-15 cm2) at 25°C, a value which does not represent optimal activity due to the thickness of the slices and to the fact that it was not measured at body temperature. In earlier experiments (1) with sarin, it appeared that approximately 90 per cent of this compound was inactivated before it reached the blood stream, and the inactivation of paraoxon might be of the same order of magnitude.
The present method of plotting the activity values makes it possible to determine the latency period mentioned earlier by extrapolation of the curves to the 100 per cent level (the broken line in Fig. I) . Following intravenous infusion, there was a latency period of 10 to 15 minutes; this period probably represents both the time necessary to build up a concentration of inhibitor high enough to produce any inactivation of the enzyme activity and the lag period due to the circulation of the blood. Following percutaneous absorption, the latency period was found to be 20 to 28 minutes. The difference between the latency period following percutaneous absorption and the one following intravenous infusion represents, thus, the actual time it takes the material to diffuse from the topical deposit to the blood stream. When curves with approximately equal slopes were chosen from both groups, the difference was found to be approximately 12 minutes. Griesemer et at. (2) have assumed that the latency period in the ease of sarin is 15 minutes, a period of time which seems reasonable in view of the evidence given above.
SUMMARY
The rate of percutaneous absorption of paraoxon (E 600, or diethyl 4-nitrophenyl phosphate) has been determined by dose-response comparison following this mode of administration and intravenous infusion in the eat. The rate of inhibition of plasma cholinesterase activity was chosen as the parameter. The enzyme activity values were plotted in a semi-logarithmic system as ordinates against time. Under the conditions of the study, the rate of percutaneous absorption was found to be constant in a given skin. The rate varied between 0.13 to 0.26 pg mm cm2 (0.47 to 0.95 mpM mm cm2). These values represent only the absorption of active material into the blood stream. The disappearance rate from the topical deposit may be considerably higher, since there are enzymes present in eat skin capable of hydrolyzing paraoxon. By extrapolation from the activity curves, it was possible to determine the time required for paraoxon to diffuse from the topical deposit to the blood stream. This latency period was found to be approximately 12 minutes.
